These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 11815767)

  • 1. Evaluation of oral budesonide for treatment of mild and moderate exacerbations of Crohn's disease in children.
    Levine A; Broide E; Stein M; Bujanover Y; Weizman Z; Dinari G; Pacht A; Branski D; Zahavi I
    J Pediatr; 2002 Jan; 140(1):75-80. PubMed ID: 11815767
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Initial therapy for mild to moderate Crohn's disease: mesalamine or budesonide?
    Feagan BG; Sandborn WJ
    Rev Gastroenterol Disord; 2002; 2 Suppl 2():S9-15. PubMed ID: 12478239
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Review article: mild to moderate Crohn's disease--defining the basis for a new treatment algorithm.
    Sandborn WJ; Feagan BG
    Aliment Pharmacol Ther; 2003 Aug; 18(3):263-77. PubMed ID: 12895211
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Budesonide in the treatment of Crohn's disease: a meta-analysis.
    Papi C; Luchetti R; Gili L; Montanti S; Koch M; Capurso L
    Aliment Pharmacol Ther; 2000 Nov; 14(11):1419-28. PubMed ID: 11069312
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Budesonide modified-release capsules.
    Baker DE
    Rev Gastroenterol Disord; 2001; 1(3):147-55. PubMed ID: 12120182
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of budesonide and mesalamine for active Crohn's disease. International Budesonide-Mesalamine Study Group.
    Thomsen OO; Cortot A; Jewell D; Wright JP; Winter T; Veloso FT; Vatn M; Persson T; Pettersson E
    N Engl J Med; 1998 Aug; 339(6):370-4. PubMed ID: 9691103
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Budesonide for maintenance of remission in Crohn's disease.
    Simms L; Steinhart AH
    Cochrane Database Syst Rev; 2001; (1):CD002913. PubMed ID: 11279777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Budesonide for induction of remission in Crohn's disease.
    Seow CH; Benchimol EI; Griffiths AM; Otley AR; Steinhart AH
    Cochrane Database Syst Rev; 2008 Jul; (3):CD000296. PubMed ID: 18646064
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Budesonide for induction of remission in Crohn's disease.
    Otley A; Steinhart AH
    Cochrane Database Syst Rev; 2005 Oct; (4):CD000296. PubMed ID: 16235274
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative Effectiveness of Mesalamine, Sulfasalazine, Corticosteroids, and Budesonide for the Induction of Remission in Crohn's Disease: A Bayesian Network Meta-analysis.
    Coward S; Kuenzig ME; Hazlewood G; Clement F; McBrien K; Holmes R; Panaccione R; Ghosh S; Seow CH; Rezaie A; Kaplan GG
    Inflamm Bowel Dis; 2017 Mar; 23(3):461-472. PubMed ID: 28146003
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enteric-coated budesonide for the induction and maintenance of remission of Crohn's disease in children.
    Cohen SA; Aloi M; Arumugam R; Baker R; Bax K; Kierkuś J; Koletzko S; Lionetti P; Persson T; Eklund S
    Curr Med Res Opin; 2017 Jul; 33(7):1261-1268. PubMed ID: 28420280
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of two dosing methods for induction of response and remission with oral budesonide in active pediatric Crohn's disease: a randomized placebo-controlled trial.
    Levine A; Kori M; Dinari G; Broide E; Shaoul R; Yerushalmi B; On A; Bujanover Y; Pröls M; Greinwald R;
    Inflamm Bowel Dis; 2009 Jul; 15(7):1055-61. PubMed ID: 19229988
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low dose oral pH modified release budesonide for maintenance of steroid induced remission in Crohn's disease. The Budesonide Study Group.
    Gross V; Andus T; Ecker KW; Raedler A; Loeschke K; Plauth M; Rasenack J; Weber A; Gierend M; Ewe K; Schölmerich J
    Gut; 1998 Apr; 42(4):493-6. PubMed ID: 9616309
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medical management of mild to moderate Crohn's disease: evidence-based treatment algorithms for induction and maintenance of remission.
    Sandborn WJ; Feagan BG; Lichtenstein GR
    Aliment Pharmacol Ther; 2007 Oct; 26(7):987-1003. PubMed ID: 17877506
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Budesonide 9 mg is at least as effective as mesalamine 4.5 g in patients with mildly to moderately active Crohn's disease.
    Tromm A; Bunganič I; Tomsová E; Tulassay Z; Lukáš M; Kykal J; Bátovský M; Fixa B; Gabalec L; Safadi R; Kramm HJ; Altorjay I; Löhr H; Koutroubakis I; Bar-Meir S; Stimac D; Schäffeler E; Glasmacher C; Dilger K; Mohrbacher R; Greinwald R;
    Gastroenterology; 2011 Feb; 140(2):425-434.e1; quiz e13-4. PubMed ID: 21070781
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Budesonide CIR capsules (once or twice daily divided-dose) in active Crohn's disease: a randomized placebo-controlled study in the United States.
    Tremaine WJ; Hanauer SB; Katz S; Winston BD; Levine JG; Persson T; Persson A;
    Am J Gastroenterol; 2002 Jul; 97(7):1748-54. PubMed ID: 12135030
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of budesonide and prednisone for the treatment of active pediatric Crohn disease.
    Levine A; Weizman Z; Broide E; Shamir R; Shaoul R; Pacht A; Dinari G; On A; Weiss B; Bujanover Y;
    J Pediatr Gastroenterol Nutr; 2003 Feb; 36(2):248-52. PubMed ID: 12548062
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Budesonide for Crohn's disease.
    Seow CH; Benchimol EI; Steinhart AH; Griffiths AM; Otley AR
    Expert Opin Drug Metab Toxicol; 2009 Aug; 5(8):971-9. PubMed ID: 19611401
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Budesonide (Entocort EC Capsules): a review of its therapeutic use in the management of active Crohn's disease in adults.
    McKeage K; Goa KL
    Drugs; 2002; 62(15):2263-82. PubMed ID: 12381231
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Budesonide and mesalazine in active Crohn's disease: a comparison of the effects on quality of life.
    Thomsen OO; Cortot A; Jewell D; Wright JP; Winter T; Veloso FT; Vatn M; Persson T; Pettersson E;
    Am J Gastroenterol; 2002 Mar; 97(3):649-53. PubMed ID: 11922560
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.